Literature DB >> 26502923

Clinicopathological Variation of Lauren Classification in Gastric Cancer.

Yun-Chi Chen1,2, Wen-Liang Fang1,2, Ruei-Fang Wang3,4, Chien-An Liu2,5, Muh-Hwa Yang6,7, Shu-Shun Lo2,8, Chew-Wen Wu1,2, Anna Fen-Yau Li2,9, Yi-Ming Shyr1,2, Kuo-Hung Huang10,11.   

Abstract

The investigation of prognostic factor for gastric cancer is still desirable because of dismal prognosis in gastric cancer. Lauren's classification is currently a useful histological classification. There are few large series evaluating the prognostic significance of Lauren's classification in gastric cancer. From January 1987 to December 2013, a total of 3071 patients received gastrectomy for gastric cancer. According Lauren's classification, 1423(46.3%) patients were intestinal type, 1000 patients (32.6%) were diffuse type, and 648 patients (21.1%) were mixed type. The clinicopathological characteristics and prognosis in Lauren's classification were analyzed in these patients. Our results showed that patients with intestinal type gastric cancer (57.7%) had a better 5-year overall survival than diffuse type (45.6%) and mixed type (43.4%, P < 0.001). The clinicopathological characteristics showed that gastric cancer patients with intestinal type were older (P < 0.001), male predominant (P < 0.001), smaller tumor size (P < 0.001), distal stomach predominant (P < 0.001), relative well differentiated (P < 0.001), less advanced Borrmann type (P < 0.001), less scirrhous type stromal reaction(P < 0.001), less infiltrating type of Ming's histology type(P < 0.001), less tumor invasion depth and less lymphovascular invasion (P < 0.001). Multivariate analysis with overall survival as an endpoint showed that age (P = 0.005), Borrmann classification (P < 0.001), pathological T category (P = 0.023), pathological N category (P < 0.001) and Lauren's classification (P = 0.003) were significant correlated in gastric cancer. Lauren's classification is an independent prognostic factor in gastric cancer patient undergoing gastrectomy. Lauren's classification can serve as a prognostic marker for gastric cancer patient receiving gastrectomy. The clinicopathological appearance and prognosis of mixed type gastric cancer is similar to diffuse type gastric cancer.

Entities:  

Keywords:  Gastrecotomy; Gastric cancer; Lauren’s classification

Mesh:

Year:  2015        PMID: 26502923     DOI: 10.1007/s12253-015-9996-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  10 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

3.  Gastric carcinoma. A pathobiological classification.

Authors:  S C Ming
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

4.  Histological mixed-type as an independent prognostic factor in stage I gastric carcinoma.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Hiroki Shimizu; Hirotaka Konishi; Atsushi Shiozaki; Hitoshi Fujiwara; Kazuma Okamoto; Mitsuo Kishimoto; Eigo Otsuji
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

5.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

Review 6.  HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.

Authors:  C Gravalos; A Jimeno
Journal:  Ann Oncol       Date:  2008-04-25       Impact factor: 32.976

Review 7.  Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value.

Authors:  Felix Berlth; Elfriede Bollschweiler; Uta Drebber; Arnulf H Hoelscher; Stefan Moenig
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

8.  Lauren classification combined with HER2 status is a better prognostic factor in Chinese gastric cancer patients.

Authors:  Miaozhen Qiu; Yixin Zhou; Xinke Zhang; Zixian Wang; Fang Wang; Jianyong Shao; Jiabin Lu; Ying Jin; Xiaoli Wei; Dongsheng Zhang; Fenghua Wang; Yuhong Li; Dajun Yang; Ruihua Xu
Journal:  BMC Cancer       Date:  2014-11-07       Impact factor: 4.430

9.  Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China.

Authors:  Miao-zhen Qiu; Mu-yan Cai; Dong-sheng Zhang; Zhi-qiang Wang; De-shen Wang; Yu-hong Li; Rui-hua Xu
Journal:  J Transl Med       Date:  2013-03-06       Impact factor: 5.531

10.  Mixed-type gastric carcinomas exhibit more aggressive features and indicate the histogenesis of carcinomas.

Authors:  Hua-chuan Zheng; Xiao-han Li; Takuo Hara; Shinji Masuda; Xiang-hong Yang; Yi-fu Guan; Yasuo Takano
Journal:  Virchows Arch       Date:  2008-05       Impact factor: 4.064

  10 in total
  76 in total

1.  Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer.

Authors:  Huan Wang; Xiao-Ming Xing; Lei-Na Ma; Lian Liu; Jing Hao; Ling-Xin Feng; Zhuang Yu
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

2.  Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis.

Authors:  Jeung Hui Pyo; Hyuk Lee; Byung-Hoon Min; Jun Haeng Lee; Min Gew Choi; Jun Ho Lee; Tae Sung Sohn; Jae Moon Bae; Kyoung-Mee Kim; Seungmin Yeon; Sin-Ho Jung; Jae J Kim; Sung Kim
Journal:  J Gastroenterol       Date:  2016-09-02       Impact factor: 7.527

Review 3.  The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis.

Authors:  John E Wang; Sung Eun Kim; Bong Eun Lee; Sungho Park; Joo Ha Hwang; Robert J Huang
Journal:  Cancer Causes Control       Date:  2021-11-19       Impact factor: 2.506

4.  Lauren classification identifies distinct prognostic value and functional status of intratumoral CD8+ T cells in gastric cancer.

Authors:  Ruochen Li; Heng Zhang; Yifan Cao; Xin Liu; Yifan Chen; Yangyang Qi; Jieti Wang; Kuan Yu; Chao Lin; Hao Liu; Hongyong He; He Li; Lingli Chen; Zhenbin Shen; Jing Qin; Weijuan Zhang; Yihong Sun; Jiejie Xu
Journal:  Cancer Immunol Immunother       Date:  2020-03-21       Impact factor: 6.968

Review 5.  Gastric cancer: a comprehensive review of current and future treatment strategies.

Authors:  Rachel E Sexton; Mohammed Najeeb Al Hallak; Maria Diab; Asfar S Azmi
Journal:  Cancer Metastasis Rev       Date:  2020-09-07       Impact factor: 9.264

6.  GEFT protein expression in digestive tract malignant tumors and its clinical significance.

Authors:  Yuanyuan Wang; Bing Zhang; Ge Gao; Yinping Zhang; Qingxin Xia
Journal:  Oncol Lett       Date:  2019-09-24       Impact factor: 2.967

7.  Delivery rate of patients with advanced gastric cancer to third-line chemotherapy and those patients' characteristics: an analysis in real-world setting.

Authors:  Masayuki Ueno; Akira Doi; Tomohiko Sunami; Hiroshi Takayama; Hirokazu Mouri; Motowo Mizuno
Journal:  J Gastrointest Oncol       Date:  2019-10

8.  Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis.

Authors:  Weilin Sun; Jingyu Deng; Nannan Zhang; Huifang Liu; Jinyuan Liu; Pengfei Gu; Yingxin Du; Zizhen Wu; Wenting He; Pengliang Wang; Han Liang
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

9.  Feasibility of differentiating T3 from T4a gastric cancer in different Lauren classification by determining serosa invasion: Diagnostic performance of high enhanced serosa sign.

Authors:  Rui-Jia Sun; Lei Tang; Ying Chen; Xiao-Ting Li; Yu Sun; Zi-Yu Li; Ying-Shi Sun
Journal:  Chin J Cancer Res       Date:  2018-04       Impact factor: 5.087

Review 10.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.